Advances on immunotherapy for osteosarcoma
S Yu, X Yao - Molecular Cancer, 2024 - Springer
Osteosarcoma is the most common primary bone cancer in children and young adults.
Limited progress has been made in improving the survival outcomes in patients with …
Limited progress has been made in improving the survival outcomes in patients with …
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Y Zheng, Y Han, Q Sun, Z Li - Exploration, 2022 - Wiley Online Library
Reprogramming the immunosuppressive tumor microenvironment by modulating
macrophages holds great promise in tumor immunotherapy. As a class of professional …
macrophages holds great promise in tumor immunotherapy. As a class of professional …
CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion
G Gunaydin - Frontiers in oncology, 2021 - frontiersin.org
Cancer associated fibroblasts (CAFs) and tumor associated macrophages (TAMs) are
among the most important and abundant players of the tumor microenvironment. CAFs as …
among the most important and abundant players of the tumor microenvironment. CAFs as …
Nanoparticle-mediated CD47-SIRPα blockade and calreticulin exposure for improved cancer chemo-immunotherapy
JQ Luo, R Liu, FM Chen, JY Zhang, SJ Zheng… - ACS …, 2023 - ACS Publications
Enabling macrophages to phagocytose tumor cells holds great potential for cancer therapy
but suffers from tremendous challenges because the tumor cells upregulate …
but suffers from tremendous challenges because the tumor cells upregulate …
Tumor-associated macrophages: An effective player of the tumor microenvironment
U Basak, T Sarkar, S Mukherjee… - Frontiers in …, 2023 - frontiersin.org
Cancer progression is primarily caused by interactions between transformed cells and the
components of the tumor microenvironment (TME). TAMs (tumor-associated macrophages) …
components of the tumor microenvironment (TME). TAMs (tumor-associated macrophages) …
Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
X Dong, J Fan, W Xie, X Wu, J Wei, Z He… - British Journal of …, 2023 - nature.com
Background Gastric cancer is one of the most common cancers. Peritoneal carcinomatosis
(PC) appears to be the most common pattern of recurrence, and more than half of the GC …
(PC) appears to be the most common pattern of recurrence, and more than half of the GC …
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
L Chibaya, J Snyder, M Ruscetti - Seminars in cancer biology, 2022 - Elsevier
Cancer therapies, including conventional chemotherapy, radiation, and molecularly targeted
agents, can lead to tumor eradication through a variety of mechanisms. In addition to their …
agents, can lead to tumor eradication through a variety of mechanisms. In addition to their …
Necroptosis enhances 'don't eat me'signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis
CY Liao, G Li, FP Kang, CF Lin, CK Xie, YD Wu… - Nature …, 2024 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer with dismal prognosis
due to distant metastasis, even in the early stage. Using RNA sequencing and multiplex …
due to distant metastasis, even in the early stage. Using RNA sequencing and multiplex …
Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy
S Beccari, V Sierra-Torre, J Valero, M Pereira-Iglesias… - Autophagy, 2023 - Taylor & Francis
Microglial phagocytosis of apoptotic debris prevents buildup damage of neighbor neurons
and inflammatory responses. Whereas microglia are very competent phagocytes under …
and inflammatory responses. Whereas microglia are very competent phagocytes under …
In vitro engineering chimeric antigen receptor macrophages and T cells by lipid nanoparticle-mediated mRNA delivery
Chimeric antigen receptor (CAR)-engineered adoptive cell therapy marks a revolution in
cancer treatment based on the highly successful responses to CAR T cell therapy in the …
cancer treatment based on the highly successful responses to CAR T cell therapy in the …